Aspire Private Capital, LLC Gsk PLC Transaction History

Aspire Private Capital, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 26, 2021	SELL	$34.27 - $40.01 $137 - $160	-4 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$34.07 - $39.94 $285,949 - $335,216	-8,393 Reduced 99.95%	4 $0
Q3 2020 Nov 13, 2020	SELL	$38.11 - $42.99 $72,485 - $81,766	-1,902 Reduced 18.47%	8,397 $316,000
Q2 2020 Aug 13, 2020	SELL	$37.87 - $43.58 $64,795 - $74,565	-1,711 Reduced 14.25%	10,299 $426,000
Q1 2020 May 14, 2020	SELL	$32.47 - $48.83 $38,054 - $57,228	-1,172 Reduced 8.89%	12,010 $455,000
Q4 2019 Feb 11, 2020	SELL	$42.0 - $48.25 $18,228 - $20,940	-434 Reduced 3.19%	13,182 $619,000
Q3 2019 Nov 12, 2019	SELL	$40.46 - $43.52 $20,836 - $22,412	-515 Reduced 3.64%	13,616 $581,000
Q2 2019 Aug 13, 2019	SELL	$39.4 - $42.7 $91,880 - $99,576	-2,332 Reduced 14.17%	14,131 $566,000
Q1 2019 May 13, 2019	SELL	$38.57 - $42.69 $78,644 - $87,044	-2,039 Reduced 11.02%	16,463 $688,000
Q4 2018 Feb 25, 2019	BUY	$37.8 - $42.69 $629,445 - $710,873	16,652 Added 900.11%	18,502 $707,000
Q4 2018 Feb 14, 2019	BUY	$37.8 - $42.69 $69,930 - $78,976	1,850 New	1,850 $707,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.2B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Aspire Private Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Aspire Private Capital, LLC with notifications on news.